期刊选题

1、投稿方式：在线投稿。

2、刊内网址：http://www.jgenetgenomics.org

http://www.elsevier.com/locate/jgg

自动跳转至：

https://www.journals.elsevier.com/journal-of-genetics-and-genomics

3、投稿系统：https://www.editorialmanager.com/jgg

4、出刊日期：月刊，每月20日出版。

2022年9月1日星期四

《遗传学报（英文版）》作者指南Guid for authors

【官网信息】

AIMS AND SCOPE

The

Journal of Genetics and Genomics (JGG, formerly known as Acta Genetica

Sinica) is an international journal publishing peer-reviewed articles of

novel and significant discoveries in the fields of genetics and

genomics. Topics of particular interest include but are not limited to

molecular genetics, developmental genetics, cytogenetics, epigenetics,

medical genetics, population and evolutionary genetics, genomics and

functional genomics as well as bioinformatics and computational biology.

The

main article types include original research, review, method article,

letter to the editor, resource, highlight, and meeting report.

Currently, JGG is indexed by Science Citation Index Expanded (SCI-E),

Medline, Scopus, Biosis Previews and Chemical Abstracts. JGG publishes

papers in English only and is distributed internationally.

Types of article

Original

Research The original research article including method article should

be organized in the following order: Title page, Abstract, Introduction,

Results, Discussion, Materials and methods, Acknowledgements,

References, Tables, and Figure legends. Figures and regular

Supplementary data should be uploaded as separate files and not as part

of the manuscript. These files will be converted, along with the

manuscript, into a single PDF on upload.

Review

The review article should be focused on topics of interest to broad

readership. It should be organized in the following order: Title Page,

Abstract, Introduction, Text with labelled topics and subtopics,

Concluding remarks (Perspectives), Acknowledgements, References, Tables,

and Figure legends. Figures should be separately uploaded and not

enclosed in the text. The length is usually not less than 5000 words.

Letter

to the Editor Letter to the Editor is a brief report on novel findings

without sufficient depth to qualify as an original research article.

There is no abstract, and only one composite figure and/or table

reflecting the main results is included. The additional results and

important materials and methods should be showed as Supplementary Data.

The length of main text (excluding the references) is limited to less

than 2000 words, and the total number of the references is limited to

20. The author's name(s) and affiliation(s) should be put at the end of

the text.

Ethics in publishing

Please see our information pages on Ethics in publishing and Ethical guidelines for journal publication.

Studies in humans and animals

If

the work involves the use of human subjects, the author should ensure

that the work described has been carried out in accordance with The Code

of Ethics of the World Medical Association (Declaration of Helsinki)

for experiments involving humans. The manuscript should be in line with

the Recommendations for the Conduct, Reporting, Editing and Publication

of Scholarly Work in Medical Journals and aim for the inclusion of

representative human populations (sex, age and ethnicity) as per those

recommendations. The terms sex and gender should be used correctly.

Authors

should include a statement in the manuscript that informed consent was

obtained for experimentation with human subjects. The privacy rights of

human subjects must always be observed.

All

animal experiments should comply with the ARRIVE guidelines and should

be carried out in accordance with the U.K. Animals (Scientific

Procedures) Act, 1986 and associated guidelines, EU Directive 2010/63/EU

for animal experiments, or the National Institutes of Health guide for

the care and use of Laboratory animals (NIH Publications No. 8023,

revised 1978) and the authors should clearly indicate in the manuscript

that such guidelines have been followed. The sex of animals must be

indicated, and where appropriate, the influence (or association) of sex

on the results of the study.

Declaration of interest

The

Journal of Genetics and Genomics follows the ICMJE recommendations

regarding conflict of interest disclosures. All authors are required to

report the following information with each submission: (1) All

third-party financial support for the work in the submitted manuscript.

(2) All financial relationships with any entities that could be viewed

as relevant to the general area of the submitted manuscript. (3) All

sources of revenue with relevance to the submitted work who made

payments to you, or to your institution on your behalf, in the 36 months

prior to submission. (4) Any other interactions with the sponsor of

outside of the submitted work should also be reported. (5) Any relevant

patents or copyrights (planned, pending, or issued). (6) Any other

relationships or affiliations that may be perceived by readers to have

influenced, or give the appearance of potentially influencing, what you

wrote in the submitted work. As a general guideline, it is usually

better to disclose a relationship than not. This information will be

acknowledged at publication in a Transparency Document link directly in

the article. Additional information on the ICMJE recommendations can be

found at: http://www.icmje.org/. The form for conflict of interest

disclosure can be downloaded here:

http://www.icmje.org/coi_disclosure.pdf (if this link does not display

properly in your browser, please right-click the link and select "Save

Target As..." or "Save Link as..." from the pop-up menu).

Submission declaration

Submission

of an article implies that the work described has not been published

previously (except in the form of an abstract, a published lecture or

academic thesis, see 'Multiple, redundant or concurrent publication' for

more information), that it is not under consideration for publication

elsewhere, that its publication is approved by all authors and tacitly

or explicitly by the responsible authorities where the work was carried

out, and that, if accepted, it will not be published elsewhere in the

same form, in English or in any other language, including electronically

without the written consent of the copyright-holder.

Use of inclusive language

Inclusive

language acknowledges diversity, conveys respect to all people, is

sensitive to differences, and promotes equal opportunities. Content

should make no assumptions about the beliefs or commitments of any

reader; contain nothing which might imply that one individual is

superior to another on the grounds of age, gender, race, ethnicity,

culture, sexual orientation, disability or health condition; and use

inclusive language throughout. Authors should ensure that writing is

free from bias, stereotypes, slang, reference to dominant culture and/or

cultural assumptions. We advise to seek gender neutrality by using

plural nouns ("clinicians, patients/clients") as default/wherever

possible to avoid using "he, she," or "he/she." We recommend avoiding

the use of descriptors that refer to personal attributes such as age,

gender, race, ethnicity, culture, sexual orientation, disability or

health condition unless they are relevant and valid. These guidelines

are meant as a point of reference to help identify appropriate language

but are by no means exhaustive or definitive.

Author contributions

For

transparency, we encourage authors to submit an author statement file

outlining their individual contributions to the paper using the relevant

CRediT roles: Conceptualization; Data curation; Formal analysis;

Funding acquisition; Investigation; Methodology; Project administration;

Resources; Software; Supervision; Validation; Visualization;

Roles/Writing - original draft; Writing - review & editing.

Authorship statements should be formatted with the names of authors

first and CRediT role(s) following. More details and an example

Subscribers

may reproduce tables of contents or prepare lists of articles including

abstracts for internal circulation within their institutions.

Permission of the Publisher is required for resale or distribution

outside the institution and for all other derivative works, including

compilations and translations. If excerpts from other copyrighted works

are included, the author(s) must obtain written permission from the

copyright owners and credit the source(s) in the article. Elsevier has

preprinted forms for use by authors in these cases. For open access

articles: Upon acceptance of an article, authors will be asked to

complete an 'Exclusive License Agreement' (more information). Permitted

third party reuse of open access articles is determined by the author's

choice of user license.

……

更多详情：

http://www.jgenetgenomics.org/news/gfa.htm